Archives of Disease in Childhood · 1993 · 47 citations · 3 references
MedicineDermatologyDermatopathologyImmunopathologyPediatric RheumatologyJuvenile DermatomyositisMuscle PathologyDisease Activity MeasurementImmune-mediated MyopathiesLongitudinal Association StudiesLongitudinal Cohort StudiesMuscle Enzyme TestingMuscle Strength ProfilingSerum Enzyme Assays
Serum neopterin concentrations were measured in 15 patients with juvenile dermatomyositis and their correlation with the severity of muscle impairment was evaluated. Neopterin concentrations were measured by radioimmunoassay. When compared with controls (median 0.75 ng/ml; range 0.33-1.18), serum neopterin concentrations were increased in patients with active juvenile dermatomyositis (median 3.21 ng/ml; range 0.95-13.81), but not in patients during remission (median 0.81 ng/ml; range 0.55-1.34). In horizontal and longitudinal studies, serum neopterin was significantly correlated with the severity of muscle strength impairment, whereas serum muscle enzyme values were not. These data suggest that measurement of serum neopterin may be used, together with clinical examination, to guide the treatment of patients with juvenile dermatomyositis.
3
A COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS
Anthony Bohan, James B. Peter, Ralph L. Bowman et al. · Medicine · 1977 · 1K citations
Autoantibodies in juvenile dermatomyositis.
Carlomaurizio Montecucco, Angelo Ravelli, Roberto Caporali et al. · PubMed · 1990 · 35 citations